World News

White House pulls nomination of Heidi Overton to lead Food and Drug Administration – as it happened

Source: World news | The Guardian · Published

White House pulls nomination of Heidi Overton to lead Food and Drug Administration – as it happened
Source: World news | The Guardian

This live blog is now closed. White House withdraws nomination of Heidi Overton to lead FDA Sign up for US Breaking News email Abdul El-Sayed , the Democratic-Senator elect from Michigan, said today that he would be happy to work with the Trump administration to pass one of his t

This live blog is now closed. White House withdraws nomination of Heidi Overton to lead FDA Sign up for US Breaking News email Abdul El-Sayed , the Democratic-Senator elect from Michigan, said today that he would be happy to work with the Trump administration to pass one of his tentpole policy agenda items – Medicare For All. “Everybody’s like, ‘ah well, you’d work with Donald Trump to get Medicare For All?’.

I’m like hell yeah, because the point for me is Medicare For All. I don’t care who puts their name on it. I need to go back and talk to Michiganders, and I need to know that our service made their lives easier,” he said at the Atlantic Summit in Washington DC.

Continue reading...

Read Original Source
White House withdraws nomination of Heidi Overton to lead FDA
World News

White House withdraws nomination of Heidi Overton to lead FDA

Move to drop Trump ally and prominent abortion opponent comes a day before key Senate health committee vote The White House has dropped its nomination of Heidi Overton to lead the Food and Drug Administration, a White House official told the Guardian. Donald Trump nominated Overt

World news | The Guardian ·

The FDA wants to pull its approval of a drug. It’s not so easy.
Technology & AI

The FDA wants to pull its approval of a drug. It’s not so easy.

In May 2021, the US Food and Drug Administration released a lengthy briefing document on an experimental medication for a rare autoimmune form of vasculitis that often damages the kidneys and lungs. The agency was on the fence about whether to approve the treatment, and it wanted

Ars Technica - All content ·